Position in SKYE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 42 holders
Holding Since
Jun 2024
9 quarters on record
Common Shares in SKYE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFS Partners, LLC holds $1,629,816 across 9 Biotechnology names. SKYE ranks #9 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
79,000 | $1,473,350 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
158 | $78,483 | |
| 3 | AVTX |
Avalo Therapeutics, Inc.
|
2,000 | $36,960 | |
| 4 | ENGN |
enGene Therapeutics Inc.
|
11,000 | $19,030 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $14,964 | |
| 6 | TECH |
BIO-TECHNE Corp
|
67 | $4,733 | |
| 7 | PRQR |
ProQR Therapeutics N.V.
|
1,000 | $1,860 | |
| 8 | EXEL |
Exelixis, Inc.
|
8 | $435 |
All Filings in SKYE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1 | 1 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1 | 1 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1 | 1 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $4 | 1 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5 | 1 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2 | 1 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $3 | 1 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $4 | 1 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1 | 1 | Shares | Sole | 2024-07-25 | |
| No filing history on record for this holder in this stock. | ||||||